198 related articles for article (PubMed ID: 24265712)
1. Mammary cells with active Wnt signaling resist ErbB2-induced tumorigenesis.
Bu W; Zhang X; Dai H; Huang S; Li Y
PLoS One; 2013; 8(11):e78720. PubMed ID: 24265712
[TBL] [Abstract][Full Text] [Related]
2. Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models.
Du Z; Podsypanina K; Huang S; McGrath A; Toneff MJ; Bogoslovskaia E; Zhang X; Moraes RC; Fluck M; Allred DC; Lewis MT; Varmus HE; Li Y
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17396-401. PubMed ID: 17090666
[TBL] [Abstract][Full Text] [Related]
3. Krt6a-positive mammary epithelial progenitors are not at increased vulnerability to tumorigenesis initiated by ErbB2.
Holloway KR; Sinha VC; Toneff MJ; Bu W; Hilsenbeck SG; Li Y
PLoS One; 2015; 10(1):e0117239. PubMed ID: 25635772
[TBL] [Abstract][Full Text] [Related]
4. Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.
Zhang J; Li Y; Liu Q; Lu W; Bu G
Oncogene; 2010 Jan; 29(4):539-49. PubMed ID: 19881541
[TBL] [Abstract][Full Text] [Related]
5. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA
Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967
[TBL] [Abstract][Full Text] [Related]
6. Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.
Peng M; Ball-Kell SM; Tyner AL
Cell Death Dis; 2015 Aug; 6(8):e1848. PubMed ID: 26247733
[TBL] [Abstract][Full Text] [Related]
7. Deregulation of the Hippo pathway in mouse mammary stem cells promotes mammary tumorigenesis.
Li H; Gumbiner BM
Mamm Genome; 2016 Dec; 27(11-12):556-564. PubMed ID: 27601049
[TBL] [Abstract][Full Text] [Related]
8. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
9. Loss of Limb-Bud-and-Heart (LBH) attenuates mammary hyperplasia and tumor development in MMTV-Wnt1 transgenic mice.
Ashad-Bishop K; Garikapati K; Lindley LE; Jorda M; Briegel KJ
Biochem Biophys Res Commun; 2019 Jan; 508(2):536-542. PubMed ID: 30509497
[TBL] [Abstract][Full Text] [Related]
10. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
[TBL] [Abstract][Full Text] [Related]
11. Reproductive history determines Erbb2 locus amplification, WNT signalling and tumour phenotype in a murine breast cancer model.
Ordonez LD; Melchor L; Greenow KR; Kendrick H; Tornillo G; Bradford J; Giles P; Smalley MJ
Dis Model Mech; 2021 May; 14(5):. PubMed ID: 34003256
[TBL] [Abstract][Full Text] [Related]
12. ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas.
Schroeder JA; Adriance MC; McConnell EJ; Thompson MC; Pockaj B; Gendler SJ
J Biol Chem; 2002 Jun; 277(25):22692-8. PubMed ID: 11950845
[TBL] [Abstract][Full Text] [Related]
13. ERBB2 overexpression suppresses stress-induced autophagy and renders ERBB2-induced mammary tumorigenesis independent of monoallelic Becn1 loss.
Lozy F; Cai-McRae X; Teplova I; Price S; Reddy A; Bhanot G; Ganesan S; Vazquez A; Karantza V
Autophagy; 2014 Apr; 10(4):662-76. PubMed ID: 24492513
[TBL] [Abstract][Full Text] [Related]
14. Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor Phenotype.
Holloway KR; Sinha VC; Bu W; Toneff M; Dong J; Peng Y; Li Y
Int J Biol Sci; 2016; 12(4):381-8. PubMed ID: 27019623
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of eIF2alpha dephosphorylation inhibits ErbB2-induced deregulation of mammary acinar morphogenesis.
Sequeira SJ; Wen HC; Avivar-Valderas A; Farias EF; Aguirre-Ghiso JA
BMC Cell Biol; 2009 Sep; 10():64. PubMed ID: 19754954
[TBL] [Abstract][Full Text] [Related]
16. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
17. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
[TBL] [Abstract][Full Text] [Related]
18. Wnt5a suppresses tumor formation and redirects tumor phenotype in MMTV-Wnt1 tumors.
Easter SL; Mitchell EH; Baxley SE; Desmond R; Frost AR; Serra R
PLoS One; 2014; 9(11):e113247. PubMed ID: 25401739
[TBL] [Abstract][Full Text] [Related]
19. The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.
Wellberg EA; Johnson S; Finlay-Schultz J; Lewis AS; Terrell KL; Sartorius CA; Abel ED; Muller WJ; Anderson SM
Breast Cancer Res; 2016 Dec; 18(1):131. PubMed ID: 27998284
[TBL] [Abstract][Full Text] [Related]
20. Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.
Sriram R; Lo V; Pryce B; Antonova L; Mears AJ; Daneshmand M; McKay B; Conway SJ; Muller WJ; Sabourin LA
Breast Cancer Res; 2015 Jan; 17(1):7. PubMed ID: 25592291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
